Demanding individually safe drugs today: overcoming the cross-labeling legal hurdle to pharmacogenomics.
Sasjack
Scott
S
Business Litigation Department, Nixon Peabody, LLP-Boston, USA.
D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D010597:Pharmacogenetics / Q000331:legislation & jurisprudence*; D014481:United States; D014486:United States Food and Drug Administration